Search

Author/Creator Cohn, Allen L.

1. A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. Issue 5 (10th February 2023)

Authors:
Makker, Vicky; Aghajanian, Carol; Cohn, Allen L.; Romeo, Margarita; Bratos, Raquel; Brose, Marcia S.; Messing, Mark; Dutta, Lea; Dutcus, Corina E.; Huang, Jie; Schmidt, Emmett V.; Orlowski, Robert; Taylor, Matthew H.
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 5(2023)
Page Start:
974
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Phase II Randomized Trial (GO27827) of First‐Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer. (16th February 2017)

Authors:
Bendell, Johanna C.; Hochster, Howard; Hart, Lowell L.; Firdaus, Irfan; Mace, Joseph R.; McFarlane, Joshua J.; Kozloff, Mark; Catenacci, Daniel; Hsu, Jessie J.; Hack, Stephen P.; Shames, David S.; Phan, See‐Chun; Koeppen, Hartmut; Cohn, Allen L.
Journal:
Oncologist
Issue:
Volume 22:Number 3(2017)
Page Start:
264
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A Phase II Randomized Trial (GO27827) of First‐Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer. (March 2017)

Authors:
Bendell, Johanna C.; Hochster, Howard; Hart, Lowell L.; Firdaus, Irfan; Mace, Joseph R.; McFarlane, Joshua J.; Kozloff, Mark; Catenacci, Daniel; Hsu, Jessie J.; Hack, Stephen P.; Shames, David S.; Phan, See‐Chun; Koeppen, Hartmut; Cohn, Allen L.
Journal:
Oncologist
Issue:
Volume 22:Number 3(2017)
Page Start:
264
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Axitinib and/or bevacizumab with modified FOLFOX‐6 as first‐line therapy for metastatic colorectal cancer: A randomized phase 2 study. Issue 14 (19th April 2013)

Authors:
Infante, Jeffrey R.; Reid, Tony R.; Cohn, Allen L.; Edenfield, William J.; Cescon, Terrence P.; Hamm, John T.; Malik, Imtiaz A.; Rado, Thomas A.; McGee, Philip J.; Richards, Donald A.; Tarazi, Jamal; Rosbrook, Brad; Kim, Sinil; Cartwright, Thomas H.
Journal:
Cancer
Issue:
Volume 119:Issue 14(2013)
Page Start:
2555
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Axitinib and/or bevacizumab with modified FOLFOX‐6 as first‐line therapy for metastatic colorectal cancer: A randomized phase 2 study. Issue 14 (19th April 2013)

Authors:
Infante, Jeffrey R.; Reid, Tony R.; Cohn, Allen L.; Edenfield, William J.; Cescon, Terrence P.; Hamm, John T.; Malik, Imtiaz A.; Rado, Thomas A.; McGee, Philip J.; Richards, Donald A.; Tarazi, Jamal; Rosbrook, Brad; Kim, Sinil; Cartwright, Thomas H.
Journal:
Cancer
Issue:
Volume 119:Issue 14(2013)
Page Start:
2555
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study†. (16th May 2014)

Authors:
Grothey, Axel; Flick, E. Dawn; Cohn, Allen L.; Bekaii‐Saab, Tanios S.; Bendell, Johanna C.; Kozloff, Mark; Roach, Nancy; Mun, Yong; Fish, Susan; Hurwitz, Herbert I.
Journal:
Pharmacoepidemiology and drug safety
Issue:
Volume 23:Number 7(2014:Jul.)
Page Start:
726
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study. (April 2023)

Authors:
Fakih, Marwan; Raghav, Kanwal Pratap Singh; Chang, David Z.; Larson, Tim; Cohn, Allen L.; Huyck, Timothy K.; Cosgrove, David; Fiorillo, Joseph A.; Tam, Rachel; D'Adamo, David; Sharma, Neelesh; Brennan, Barbara J.; Wang, Ying A.; Coppieters, Sabine; Zebger-Gong, Hong; Weispfenning, Anke; Seidel, H...
Journal:
EClinicalMedicine
Issue:
Volume 58(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first‐line treatment of metastatic colorectal cancer. Issue 24 (1st October 2013)

Authors:
Fuchs, Charles S.; Fakih, Marwan; Schwartzberg, Lee; Cohn, Allen L.; Yee, Lorrin; Dreisbach, Luke; Kozloff, Mark F.; Hei, Yong‐jiang; Galimi, Francesco; Pan, Yang; Haddad, Vincent; Hsu, Cheng‐Pang; Sabin, Antony; Saltz, Leonard
Journal:
Cancer
Issue:
Volume 119:Issue 24(2013)
Page Start:
4290
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first‐line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trial. Issue 24 (1st October 2013)

Authors:
Fuchs, Charles S.; Fakih, Marwan; Schwartzberg, Lee; Cohn, Allen L.; Yee, Lorrin; Dreisbach, Luke; Kozloff, Mark F.; Hei, Yong‐jiang; Galimi, Francesco; Pan, Yang; Haddad, Vincent; Hsu, Cheng‐Pang; Sabin, Antony; Saltz, Leonard
Journal:
Cancer
Issue:
Volume 119:Issue 24(2013)
Page Start:
4290
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗